RBC's Top 30 Global Stock Investments for 2022

Inflation. Supply-chain issues. COVID. Investors face numerous hurdles in 2022, but RBC is confident in these 30 stocks' ability to weather the storm.

Concept art showing the world with points of light based on heavy-density population areas.
(Image credit: Getty Images)

It will be tough to top the S&P 500's whopper of a performance in 2021. But investors can still look forward to "solid" if more "moderate" returns in the year ahead, says RBC Capital Markets – and perhaps even better with the right stock investments.

"The overall outlook for the next six to 12 months remains optimistic due to strong assessments for fundamentals, valuations, cash deployment and margins, balanced by more cautious views regarding fiscal policy," writes the U.S. Equity Strategy team at RBC.

True, COVID-19, inflation, labor, supply chain, pricing power and regulation remain key concerns, the strategists note. However, RBC industry analysts remain "generally confident in their companies' ability to manage through challenges, including omicron."

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

With those factors in mind, RBC Capital Markets has put together a list of their top 30 global stock investments for the year ahead. The equity strategy team's picks span the market's 11 major sectors, and in many cases overlap with Kiplinger's own 22 best stocks to buy for 2022.

Some highlights include:

  • S&P Global (SPGI, $435.39). The provider of financial information, analytics and credit ratings products ranks as one of Wall Street's 12 best financial stocks. RBC is on board as well, thanks to the firm's strategic acquisition of IHS Markit (INFO). The deal, which is expected to close in the first quarter, "should accelerate [SPGI's] revenue growth profile and deliver double-digit earnings growth driven by upside to revenue and cost synergies," RBC says. (Share prices as of Jan. 10. Analysts' consensus recommendations and other data courtesy of S&P Global Market Intelligence, unless otherwise noted.)
  • ConocoPhillips (COP, $81.03). The independent oil and gas exploration & production company "offers a returns-focused value proposition, a strong balance sheet, and peer-leading distributions," RBC says. The broader analyst community definitely agrees, giving COP a consensus recommendation of Buy, with high conviction, according to S&P Global Market Intelligence. Indeed, the Street is so bullish on the name that SPGI makes the list of 9 best energy stocks to buy for 2022.
  • UnitedHeath Group (UNH, $465.00). The nation's largest health insurer by market value and revenue routinely ranks among analysts' top-rated Dow Jones Industrial Average stocks, and makes the list of Wall Street's 12 best healthcare stocks to buy for 2022, as well. "Despite its scale, we believe the company offers investors a strong growth profile and excellent visibility, with earnings per share increasing at a targeted 13% to 16% clip annually," notes RBC.

See the table below for RBC Capital Market's full list of 30 best global stock investments for 2022. And be sure to check out Wall Street's top stocks to buy across individual market sectors, including analysts' 12 best industrial stocks to buy for 2022, their 12 best real estate investment trusts (REITs) and their top 12 communications services stocks for the new year.

A table of RBC's 30 best stock investments for 2022

(Image credit: RBC Capital Markets)
Dan Burrows
Senior Investing Writer, Kiplinger.com

Dan Burrows is Kiplinger's senior investing writer, having joined the august publication full time in 2016.


A long-time financial journalist, Dan is a veteran of SmartMoney, MarketWatch, CBS MoneyWatch, InvestorPlace and DailyFinance. He has written for The Wall Street Journal, Bloomberg, Consumer Reports, Senior Executive and Boston magazine, and his stories have appeared in the New York Daily News, the San Jose Mercury News and Investor's Business Daily, among other publications. As a senior writer at AOL's DailyFinance, Dan reported market news from the floor of the New York Stock Exchange and hosted a weekly video segment on equities.


Once upon a time – before his days as a financial reporter and assistant financial editor at legendary fashion trade paper Women's Wear Daily – Dan worked for Spy magazine, scribbled away at Time Inc. and contributed to Maxim magazine back when lad mags were a thing. He's also written for Esquire magazine's Dubious Achievements Awards.


In his current role at Kiplinger, Dan writes about equities, fixed income, currencies, commodities, funds, macroeconomics, demographics, real estate, cost of living indexes and more.


Dan holds a bachelor's degree from Oberlin College and a master's degree from Columbia University.


Disclosure: Dan does not trade stocks or other securities. Rather, he dollar-cost averages into cheap funds and index funds and holds them forever in tax-advantaged accounts.